Production (Stage)
Medpace Holdings, Inc.
MEDP
$447.49
-$8.19-1.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.24% | 9.30% | 7.66% | 8.29% | 14.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.24% | 9.30% | 7.66% | 8.29% | 14.59% |
| Cost of Revenue | 8.33% | 3.69% | 1.97% | 4.37% | 8.21% |
| Gross Profit | 17.09% | 12.13% | 10.46% | 10.25% | 17.93% |
| SG&A Expenses | 12.57% | 31.34% | 6.87% | 18.86% | 5.20% |
| Depreciation & Amortization | -3.05% | -0.89% | 7.66% | 9.31% | 10.97% |
| Other Operating Expenses | 17.14% | 9.76% | -3.32% | -1.11% | 13.87% |
| Total Operating Expenses | 12.77% | 9.35% | 0.03% | 3.30% | 10.58% |
| Operating Income | 20.15% | 9.08% | 43.58% | 32.23% | 34.13% |
| Income Before Tax | 12.72% | 4.78% | 47.60% | 42.76% | 45.86% |
| Income Tax Expenses | 54.89% | -64.92% | 35.90% | 76.67% | 50.80% |
| Earnings from Continuing Operations | 2.16% | 11.70% | 49.45% | 36.68% | 44.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.16% | 11.70% | 49.45% | 36.68% | 44.68% |
| EBIT | 20.15% | 9.08% | 43.58% | 32.23% | 34.13% |
| EBITDA | 18.65% | 8.46% | 40.93% | 30.51% | 32.35% |
| EPS Basic | 10.69% | 13.43% | 48.46% | 34.93% | 42.66% |
| Normalized Basic EPS | 22.14% | 6.35% | 46.52% | 40.84% | 43.73% |
| EPS Diluted | 12.73% | 14.69% | 49.22% | 35.59% | 42.49% |
| Normalized Diluted EPS | 24.10% | 7.48% | 47.37% | 41.31% | 43.54% |
| Average Basic Shares Outstanding | -7.71% | -1.48% | 0.74% | 1.36% | 1.48% |
| Average Diluted Shares Outstanding | -9.17% | -2.52% | 0.15% | 1.03% | 1.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |